Table 3.
Pathway analysis of cDNA arrays
Drug | SVM Pathways | MNI Pathways | Known MoA |
---|---|---|---|
Terbinafine | Ergosterol biosynthetic process (27) | Steroid metabolism (2130) | Inhibition of squalene monooxygenase, thus blocking the biosynthesis of ergosterol |
Lovastatin | - | Lipid metabolism (16244) | Inhibition of HMG-CoA reductase |
Itraconazole | Ergosterol biosynthetic process (256) | Steroid metabolism (2130) | Interaction with 14-α demethylase an enzyme necessary to convert lanosterol to ergosterol. |
Hydroxyurea | Deoxyribonucleotide biosynthetic process (704) | Dna replication (5480) | Inhibition of ribonucleotide reductase and consequently of DNA synthesis |
Tunicamycin | Cellular nitrogen compound catabolic process (6678), Protein targeting to ER (585) | Protein-ER targeting (585) | N-linked glycosylation |